Tol2 gene trap integrations in the zebrafish amyloid precursor protein genes appa and aplp2 reveal accumulation of secreted APP at the embryonic veins

Developmental Dynamics

Volumn 241, Issue 2, 2012, Pages 415-425

  Liao, Hsin Kai ^a   Wang, Ying ^a   Noack Watt, Kristin E ^a   Wen, Qin ^a   Breitbach, Justin ^a   Kemmet, Chelsy K ^a   Clark, Karl J ^b   Ekker, Stephen C ^b   Essner, Jeffrey J ^a   McGrail, Maura ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Central nervous system; Endothelial cells; Tol2 gene trap; Vasculature; Vein

Indexed keywords

AMYLOID PRECURSOR LIKE PROTEIN 2; AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN A; RED FLUORESCENT PROTEIN; TOL2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD FLOW; CENTRAL NERVOUS SYSTEM; DNA INTEGRATION; PRIORITY JOURNAL; PROTEIN BINDING; TRANSPOSON; ZEBRA FISH;

ALLELES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOGENIC PROTEINS; ANIMALS; DNA TRANSPOSABLE ELEMENTS; FLUORESCENT DYES; GENETIC TECHNIQUES; LUMINESCENT PROTEINS; MUTAGENESIS, INSERTIONAL; VEINS; ZEBRAFISH; ZEBRAFISH PROTEINS;

DANIO RERIO;

EID: 84862913229     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.23725     Document Type: Article

References (51)

1. Arai H, Lee VM, Messinger ML, Greenberg BD, Lowery DE, Trojanowski JQ. 1991. Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. Ann Neurol 30: 686-693.
2. Araki W, Kitaguchi N, Tokushima Y, Ishii K, Aratake H, Shimohama S, Nakamura S, Kimura J. 1991. Trophic effect of beta-amyloid precursor protein on cerebral cortical neurons in culture. Biochem Biophys Res Commun 181: 265-271.
3. Asakawa K, Kawakami K. 2009. The Tol2-mediated Gal4-UAS method for gene and enhancer trapping in zebrafish. Methods 49: 275-281.
4. Bailey TL, Rivara CB, Rocher AB, Hof PR. 2004. The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol Res 26: 573-578.
5. Balciunas D, Ekker SC. 2005. Trapping fish genes with transposons. Zebrafish 1: 335-341.
6. Balciunas D, Davidson AE, Sivasubbu S, Hermanson SB, Welle Z, Ekker SC. 2004. Enhancer trapping in zebrafish using the Sleeping Beauty transposon. BMC Genomics 5: 62.
7. Balciunas D, Wangensteen KJ, Wilber A, Bell J, Geurts A, Sivasubbu S, Wang X, Hackett PB, Largaespada DA, McIvor RS, Ekker SC. 2006. Harnessing a high cargo-capacity transposon for genetic applications in vertebrates. PLoS Genet 2: e169.
8. Cabal A, Alonso-Cortina V, Gonzalez-Vazquez LO, Naves FJ, Del Valle ME, Vega JA. 1995. beta-Amyloid precursor protein (beta APP) in human gut with special reference to the enteric nervous system. Brain Res Bull 38: 417-423.
9. Choo BG, Kondrichin I, Parinov S, Emelyanov A, Go W, Toh WC, Korzh V. 2006. Zebrafish transgenic Enhancer TRAP line database (ZETRAP). BMC Dev Biol 6: 5.
10. Clark KJ, Balciunas D, Pogoda HM, Ding Y, Westcot SE, Bedell VM, Greenwood TM, Urban MD, Skuster KJ, Petzold AM, Ni J, Nielsen AL, Patowary A, Scaria V, Sivasubbu S, Xu X, Hammerschmidt M, Ekker SC. 2011. In vivo protein trapping produces a functional expression codex of the vertebrate proteome. Nat Methods 8: 506-515.
11. Gama Sosa MA, Gasperi RD, Rocher AB, Wang AC, Janssen WG, Flores T, Perez GM, Schmeidler J, Dickstein DL, Hof PR, Elder GA. 2010. Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations. Am J Pathol 176: 353-368.
12. Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC. 1987. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235: 877-880.
13. Goodman Y, Mattson MP. 1994. Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp Neurol 128: 1-12.
14. Gralle M, Ferreira ST. 2007. Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts. Prog Neurobiol 82: 11-32.
15. Hornsten A, Lieberthal J, Fadia S, Malins R, Ha L, Xu X, Daigle I, Markowitz M, O'Connor G, Plasterk R, Li C. 2007. APL-1, a Caenorhabditis elegans protein related to the human beta-amyloid precursor protein, is essential for viability. Proc Natl Acad Sci U S A 104: 1971-1976.
16. Ivics Z, Izsvak Z. 2010. The expanding universe of transposon technologies for gene and cell engineering. Mob DNA 1: 25.
17. Jacobsen KT, Iverfeldt K. 2009. Amyloid precursor protein and its homologues: a family of proteolysis-dependent receptors. Cell Mol Life Sci 66: 2299-2318.
18. Jelen N, Ule J, Zivin M, Darnell RB. 2007. Evolution of Nova-dependent splicing regulation in the brain. PLoS Genet 3: 1838-1847.
19. Jin SW, Beis D, Mitchell T, Chen JN, Stainier DY. 2005. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development 132: 5199-5209.
20. Joshi P, Liang JO, DiMonte K, Sullivan J, Pimplikar SW. 2009. Amyloid precursor protein is required for convergent-extension movements during Zebrafish development. Dev Biol 335: 1-11.
21. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736.
22. Kawakami K. 2007. Tol2: a versatile gene transfer vector in vertebrates. Genome Biol 8(suppl 1): S7.
23. Kawakami K, Takeda H, Kawakami N, Kobayashi M, Matsuda N, Mishina M. 2004. A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish. Dev Cell 7: 133-144.
24. Kawakami K, Abe G, Asada T, Asakawa K, Fukuda R, Ito A, Lal P, Mouri N, Muto A, Suster ML, Takakubo H, Urasaki A, Wada H, Yoshida M. 2010. zTrap: zebrafish gene trap and enhancer trap database. BMC Dev Biol 10: 105.
25. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. 1995. Stages of embryonic development of the zebrafish. Dev Dyn 203: 253-310.
26. Kostka G, Giltay R, Bloch W, Addicks K, Timpl R, Fassler R, Chu ML. 2001. Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice. Mol Cell Biol 21: 7025-7034.
27. Kumar-Singh S. 2008. Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques. Genes Brain Behav 7(suppl 1): 67-82.
28. Lannfelt L, Basun H, Wahlund LO, Rowe BA, Wagner SL. 1995. Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nat Med 1: 829-832.
29. Largaespada DA. 2009. Transposon mutagenesis in mice. Methods Mol Biol 530: 379-390.
30. Larson JD, Wadman SA, Chen E, Kerley L, Clark KJ, Eide M, Lippert S, Nasevicius A, Ekker SC, Hackett PB, Essner JJ. 2004. Expression of VE-cadherin in zebrafish embryos: a new tool to evaluate vascular development. Dev Dyn 231: 204-213.
31. Lee JA, Cole GJ. 2007. Generation of transgenic zebrafish expressing green fluorescent protein under control of zebrafish amyloid precursor protein gene regulatory elements. Zebrafish 4: 277-286.
32. Ma QH, Futagawa T, Yang WL, Jiang XD, Zeng L, Takeda Y, Xu RX, Bagnard D, Schachner M, Furley AJ, Karagogeos D, Watanabe K, Dawe GS, Xiao ZC. 2008. A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis. Nat Cell Biol 10: 283-294.
33. McGrail M, Batz L, Noack K, Pandey S, Huang Y, Gu X, Essner JJ. 2010. Expression of the zebrafish CD133/prominin1 genes in cellular proliferation zones in the embryonic central nervous system and sensory organs. Dev Dyn 239: 1849-1857.
34. McGrail M, Hatler JM, Kuang X, Liao HK, Nannapaneni K, Watt KE, Uhl JD, Largaespada DA, Vollbrecht E, Scheetz TE, Dupuy AJ, Hostetter JM, Essner JJ. 2011. Somatic mutagenesis with a Sleeping Beauty transposon system leads to solid tumor formation in zebrafish. PLoS One 6: e18826.
35. Musa A, Lehrach H, Russo VA. 2001. Distinct expression patterns of two zebrafish homologues of the human APP gene during embryonic development. Dev Genes Evol 211: 563-567.
36. Newman M, Musgrave IF, Lardelli M. 2007. Alzheimer disease: amyloidogenesis, the presenilins and animal models. Biochim Biophys Acta 1772: 285-297.
37. Ohsawa I, Takamura C, Kohsaka S. 2001. Fibulin-1 binds the amino-terminal head of beta-amyloid precursor protein and modulates its physiological function. J Neurochem 76: 1411-1420.
38. Parinov S, Kondrichin I, Korzh V, Emelyanov A. 2004. Tol2 transposon-mediated enhancer trap to identify developmentally regulated zebrafish genes in vivo. Dev Dyn 231: 449-459.
39. Petzold AM, Balciunas D, Sivasubbu S, Clark KJ, Bedell VM, Westcot SE, Myers SR, Moulder GL, Thomas MJ, Ekker SC. 2009. Nicotine response genetics in the zebrafish. Proc Natl Acad Sci U S A 106: 18662-18667.
40. Philipson O, Lord A, Gumucio A, O'Callaghan P, Lannfelt L, Nilsson LN. 2010. Animal models of amyloid-beta-related pathologies in Alzheimer's disease. FEBS J 277: 1389-1409.
41. Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, Holton JL. 2003. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 62: 885-898.
42. Sehnert AJ, Huq A, Weinstein BM, Walker C, Fishman M, Stainier DY. 2002. Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet 31: 106-110.
43. Sivasubbu S, Balciunas D, Amsterdam A, Ekker SC. 2007. Insertional mutagenesis strategies in zebrafish. Genome Biol 8(suppl 1): S9.
44. Small DH, Nurcombe V, Reed G, Clarris H, Moir R, Beyreuther K, Masters CL. 1994. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J Neurosci 14: 2117-2127.
45. Storkebaum E, Quaegebeur A, Vikkula M, Carmeliet P. 2011. Cerebrovascular disorders: molecular insights and therapeutic opportunities. Nat Neurosci 14: 1390-1397.
46. Suster ML, Kikuta H, Urasaki A, Asakawa K, Kawakami K. 2009. Transgenesis in zebrafish with the tol2 transposon system. Methods Mol Biol 561: 41-63.
47. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
48. Tanzi RE, Gusella JF, Watkins PC, Bruns GA, St George-Hyslop P, Van Keuren ML, Patterson D, Pagan S, Kurnit DM, Neve RL. 1987. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235: 880-884.
49. Wang Y, Kaiser MS, Larson JD, Nasevicius A, Clark KJ, Wadman SA, Roberg-Perez SE, Ekker SC, Hackett PB, McGrail M, Essner JJ. 2010. Moesin1 and Ve-cadherin are required in endothelial cells during in vivo tubulogenesis. Development 137: 3119-3128.
50. Weyer SW, Klevanski M, Delekate A, Voikar V, Aydin D, Hick M, Filippov M, Drost N, Schaller KL, Saar M, Vogt MA, Gass P, Samanta A, Jaschke A, Korte M, Wolfer DP, Caldwell JH, Muller UC. 2011. APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP. EMBO J 30: 2266-2280.
51. Xie L, Palmsten K, MacDonald B, Kieran MW, Potenta S, Vong S, Kalluri R. 2008. Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth. Exp Biol Med (Maywood) 233: 155-162.